BlackRock’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33 | Hold |
4
| – | – | ﹤0.01% | 5647 |
|
|
2026
Q1 | $65 | Sell |
4
-6
| -60% | -$157 | ﹤0.01% | 5624 |
|
|
2025
Q4 | $202 | Hold |
10
| – | – | ﹤0.01% | 5458 |
|
|
2025
Q3 | $87 | Hold |
10
| – | – | ﹤0.01% | 5407 |
|
|
2025
Q2 | $32 | Hold |
10
| – | – | ﹤0.01% | 5425 |
|
|
2025
Q1 | $45 | Buy |
10
+4
| +67% | +$25 | ﹤0.01% | 5390 |
|
|
2024
Q4 | $41 | Hold |
6
| – | – | ﹤0.01% | 5363 |
|
|
2024
Q3 | $20 | Hold |
6
| – | – | ﹤0.01% | 5201 |
|
|
2024
Q2 | $39 | Sell |
6
-1
| -14% | -$8 | ﹤0.01% | 5256 |
|
|
2024
Q1 | $47 | Hold |
7
| – | – | ﹤0.01% | 5263 |
|
|
2023
Q4 | $60 | Sell |
7
-131
| -95% | -$1.21K | ﹤0.01% | 5340 |
|
|
2023
Q3 | $1.34K | Sell |
138
-4,054
| -97% | -$63.3K | ﹤0.01% | 5315 |
|
|
2023
Q2 | $90.1K | Hold |
4,192
| – | – | ﹤0.01% | 4946 |
|
|
2023
Q1 | $118K | Sell |
4,192
-1,015
| -19% | -$30.4K | ﹤0.01% | 4921 |
|
|
2022
Q4 | $117K | Sell |
5,207
-150,599
| -97% | -$3.44M | ﹤0.01% | 4992 |
|
|
2022
Q3 | $3.72M | Sell |
155,806
-7,146
| -4% | -$231K | ﹤0.01% | 3888 |
|
|
2022
Q2 | $4.74M | Buy |
162,952
+19,277
| +13% | +$861K | ﹤0.01% | 3843 |
|
|
2022
Q1 | $13.3M | Buy |
143,675
+14,053
| +11% | +$1.22M | ﹤0.01% | 3420 |
|
|
2021
Q4 | $12.4M | Sell |
129,622
-54,301
| -30% | -$7.44M | ﹤0.01% | 3547 |
|
|
2021
Q3 | $32.9M | Buy |
183,923
+10,392
| +6% | +$2.31M | ﹤0.01% | 2939 |
|
|
2021
Q2 | $51.1M | Buy |
+173,531
| New | +$51.3M | ﹤0.01% | 2690 |
|
Other funds holding BNR
BlackRock's BNR Position: Q2 2026 in Review
BlackRock held its Burning Rock Biotech (BNR) position steady in Q2 2026 at 4 shares worth $33. The position accounts for ﹤0.01% of the portfolio, ranked #5647.
BlackRock first reported a position in BNR in Q2 2021 and has held it in 21 quarters since. The position peaked at $51.1M in Q2 2021. 3 funds tracked by Wall St. Rank hold BNR as of Q2 2026.
- BlackRock held 4 shares of Burning Rock Biotech worth $33 as of Q2 2026.
- BlackRock left its Burning Rock Biotech share count unchanged in Q2 2026.
- Burning Rock Biotech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5647 holding.
- BlackRock first reported a position in Burning Rock Biotech in Q2 2021 and has held it in 21 quarters since.
- BlackRock's Burning Rock Biotech position peaked at $51.1M in Q2 2021.
- 3 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.